Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Persistent nociception induces anxiety-like behavior in rodents: role of endogenous neuropeptide S.

Zhang S, Jin X, You Z, Wang S, Lim G, Yang J, McCabe M, Li N, Marota J, Chen L, Mao J.

Pain. 2014 Aug;155(8):1504-15. doi: 10.1016/j.pain.2014.04.026. Epub 2014 May 2.

2.

Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala.

Diaz MR, Chappell AM, Christian DT, Anderson NJ, McCool BA.

Neuropsychopharmacology. 2011 Apr;36(5):1090-103. doi: 10.1038/npp.2010.246. Epub 2011 Jan 26.

3.

Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors.

Ren W, Kiritoshi T, Grégoire S, Ji G, Guerrini R, Calo G, Neugebauer V.

J Neurophysiol. 2013 Oct;110(8):1765-81. doi: 10.1152/jn.00874.2012. Epub 2013 Jul 24.

4.

Anxiety-like behavior is modulated by a discrete subpopulation of interneurons in the basolateral amygdala.

Truitt WA, Johnson PL, Dietrich AD, Fitz SD, Shekhar A.

Neuroscience. 2009 May 5;160(2):284-94. doi: 10.1016/j.neuroscience.2009.01.083. Epub 2009 Mar 1.

5.

Neuropeptide S modulates the amygdaloidal HCN activities (Ih) in rats: Implication in chronic pain.

Zhang S, You Z, Wang S, Yang J, Yang L, Sun Y, Mi W, Yang L, McCabe MF, Shen S, Chen L, Mao J.

Neuropharmacology. 2016 Jun;105:420-33. doi: 10.1016/j.neuropharm.2016.02.004. Epub 2016 Feb 21.

PMID:
26855147
6.

Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala.

Jüngling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, Clark SD, Okamura N, Duangdao DM, Xu YL, Reinscheid RK, Pape HC.

Neuron. 2008 Jul 31;59(2):298-310. doi: 10.1016/j.neuron.2008.07.002.

7.

Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of beta 3 adrenoceptor activation.

Silberman Y, Ariwodola OJ, Chappell AM, Yorgason JT, Weiner JL.

Neuropsychopharmacology. 2010 Aug;35(9):1886-96. doi: 10.1038/npp.2010.59. Epub 2010 Apr 21.

8.
9.

Nasal application of neuropeptide S inhibits arthritis pain-related behaviors through an action in the amygdala.

Medina G, Ji G, Grégoire S, Neugebauer V.

Mol Pain. 2014 May 29;10:32. doi: 10.1186/1744-8069-10-32.

10.

Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster.

Avolio E, Alò R, Carelli A, Canonaco M.

Behav Brain Res. 2011 Apr 15;218(2):288-95. doi: 10.1016/j.bbr.2010.11.014. Epub 2010 Nov 11.

PMID:
21074570
11.

Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models.

Dwyer JM, Rizzo SJ, Neal SJ, Lin Q, Jow F, Arias RL, Rosenzweig-Lipson S, Dunlop J, Beyer CE.

Psychopharmacology (Berl). 2009 Mar;203(1):41-52. doi: 10.1007/s00213-008-1373-7. Epub 2008 Oct 24.

PMID:
18949460
12.

Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression.

Wegener G, Finger BC, Elfving B, Keller K, Liebenberg N, Fischer CW, Singewald N, Slattery DA, Neumann ID, Mathé AA.

Int J Neuropsychopharmacol. 2012 Apr;15(3):375-87. doi: 10.1017/S1461145711000678. Epub 2011 May 9.

PMID:
21708052
13.
14.

Increased anxiety-like behavior and enhanced synaptic efficacy in the amygdala of GluR5 knockout mice.

Wu LJ, Ko SW, Toyoda H, Zhao MG, Xu H, Vadakkan KI, Ren M, Knifed E, Shum F, Quan J, Zhang XH, Zhuo M.

PLoS One. 2007 Jan 24;2(1):e167.

15.
16.

Amygdala NRG1-ErbB4 is critical for the modulation of anxiety-like behaviors.

Bi LL, Sun XD, Zhang J, Lu YS, Chen YH, Wang J, Geng F, Liu F, Zhang M, Liu JH, Li XW, Mei L, Gao TM.

Neuropsychopharmacology. 2015 Mar;40(4):974-86. doi: 10.1038/npp.2014.274. Epub 2014 Oct 13.

17.
18.
19.

GABAA receptors in the central nucleus of amygdala (CeA) affect on pain modulation.

Hasanein P, Mirazi N, Javanmardi K.

Brain Res. 2008 Nov 19;1241:36-41. doi: 10.1016/j.brainres.2008.09.041. Epub 2008 Sep 24.

PMID:
18838064
20.

Prevention of stress-impaired fear extinction through neuropeptide s action in the lateral amygdala.

Chauveau F, Lange MD, Jüngling K, Lesting J, Seidenbecher T, Pape HC.

Neuropsychopharmacology. 2012 Jun;37(7):1588-99. doi: 10.1038/npp.2012.3. Epub 2012 Feb 1.

Items per page

Supplemental Content

Write to the Help Desk